Clinical Trials Directory

Trials / Completed

CompletedNCT04590144

Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
446 (actual)
Sponsor
MicroPort CRM · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to assess the safety and key electrical performance of the INVICTA leads equipped with DF4 connector: ACTIVE fixation type models (single and dual coil: INVICTA 1CR, INVICTA 2CR)

Detailed description

APOLLO study is a pre-market approval (INVICTA leads - devices under investigation - are not CE marked), interventional, prospective, longitudinal, international (European), multicenter, single arm study. The devices under investigation, the INVICTA defibrillation leads, are new quadripolar leads, to be used with Implantable Cardiac Defibrillators and Cardiac Resynchronization Therapy Defibrillators (ICD/CRT-D). This clinical study intends to demonstrate safety and electrical performances of the INVICTA leads among the different models: active fixation either single coil (model 1CR) or dual coil (model 2CR)leads models. The clinical data will be used to support the application to CE marking of INVICTA leads. The primary endpoints will be evaluated at 3 months post-implantation; secondary endpoints will be evaluated up to 2 years post-implantation. A total number of 445 patients will be enrolled in the study, in up to 60 centers in Europe. The follow-up visits are scheduled at hospital discharge, at 1 month, at 3 months, at 6 months, at 12 months, at 18 months and at 24 months, post-implant

Conditions

Interventions

TypeNameDescription
DEVICEINVICTA leadThe implant or the attempt to implant an INVICTA lead

Timeline

Start date
2021-06-04
Primary completion
2022-03-16
Completion
2024-12-23
First posted
2020-10-19
Last updated
2025-07-24

Locations

45 sites across 8 countries: Austria, France, Germany, Italy, Netherlands, Portugal, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT04590144. Inclusion in this directory is not an endorsement.